TY - JOUR
T1 - Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth
AU - Sun, Leon L.
AU - Xu, Linda L.
AU - Nielsen, Thor B.
AU - Rhee, Peter
AU - Burris, David
N1 - Funding Information:
1The project was funded by the Naval Medical Research and Development Command (61153N MR04120.001-1421 and G0190EP). The authors gratefully acknowledge Mr. Fleetwood A. Henry and HM3 Yusef Miller for excellent technical assistance. 2 To whom correspondence should be addressed at CPDR, Department of Surgery, Uniformed Services University of the Health Sciences, 1530 East Jefferson Street, Rockville, MD 20852. Fax: (240) 453-8912. E-mail: lsun@usuhs.mil.
PY - 1999/11
Y1 - 1999/11
N2 - Background. N6-Cyclopentyladenosine (CPA), a structural analog of adenosine, is a vasodilator with extensive pharmacological effects. However, little is known about the effect of CPA on wound healing and hair growth. Methods. Cellular responses to CPA were measured in vitro by tetrazolium dye reduction and in vivo by bromodeoxyuridine (BrdU) uptake. The effect of CPA on healing of incisional and excisional wounds on the dorsum of diabetic (db/db, n = 94) and nondiabetic (dbl+, n = 20) mice and hair growth along the wound margin was evaluated with wound breaking strength, wound closure rate, and quantitative histology. Results. CPA stimulated proliferation of BALB/3T3 fibroblasts and human dermal microvascular endothelial cells in both quiescent and nonquiescent phases. Wounds treated with CPA at 10 μM showed a significant increase in the number of BrdU-labeled cells, including keratinocytes, fibroblasts, endothelial cells, and cells in sebaceous glands and the outer root sheath of hair follicles, compared with controls (P < 0.05). CPA application (5.1 μg/daily for 12 days) significantly increased the breaking strength of incisional wounds at day 24 postwound (P < 0.05). Excisional wound closure rate in the CPA-treated group (3.4 μg/daily for 15 days) was accelerated starting at day 10 postwound compared with controls (P < 0.01). Tissue sections from CPA-treated wounds showed a sevenfold increase in hair follicle number, compared with controls (P < 0.01). Enhanced hair growth along the wound margin was revealed in CPA-treated groups. Conclusion. CPA stimulated proliferation of many cell types in vivo and in vitro and enhanced wound healing and hair growth. Therefore, CPA could be an interesting candidate for clinical application.
AB - Background. N6-Cyclopentyladenosine (CPA), a structural analog of adenosine, is a vasodilator with extensive pharmacological effects. However, little is known about the effect of CPA on wound healing and hair growth. Methods. Cellular responses to CPA were measured in vitro by tetrazolium dye reduction and in vivo by bromodeoxyuridine (BrdU) uptake. The effect of CPA on healing of incisional and excisional wounds on the dorsum of diabetic (db/db, n = 94) and nondiabetic (dbl+, n = 20) mice and hair growth along the wound margin was evaluated with wound breaking strength, wound closure rate, and quantitative histology. Results. CPA stimulated proliferation of BALB/3T3 fibroblasts and human dermal microvascular endothelial cells in both quiescent and nonquiescent phases. Wounds treated with CPA at 10 μM showed a significant increase in the number of BrdU-labeled cells, including keratinocytes, fibroblasts, endothelial cells, and cells in sebaceous glands and the outer root sheath of hair follicles, compared with controls (P < 0.05). CPA application (5.1 μg/daily for 12 days) significantly increased the breaking strength of incisional wounds at day 24 postwound (P < 0.05). Excisional wound closure rate in the CPA-treated group (3.4 μg/daily for 15 days) was accelerated starting at day 10 postwound compared with controls (P < 0.01). Tissue sections from CPA-treated wounds showed a sevenfold increase in hair follicle number, compared with controls (P < 0.01). Enhanced hair growth along the wound margin was revealed in CPA-treated groups. Conclusion. CPA stimulated proliferation of many cell types in vivo and in vitro and enhanced wound healing and hair growth. Therefore, CPA could be an interesting candidate for clinical application.
KW - Angiogenesis
KW - Bromodeoxyuridine
KW - Hair follicle
KW - Wound strength
UR - http://www.scopus.com/inward/record.url?scp=0032693642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032693642&partnerID=8YFLogxK
U2 - 10.1006/jsre.1999.5716
DO - 10.1006/jsre.1999.5716
M3 - Article
C2 - 10527699
AN - SCOPUS:0032693642
SN - 0022-4804
VL - 87
SP - 14
EP - 24
JO - Journal of Surgical Research
JF - Journal of Surgical Research
IS - 1
ER -